The Limited Times

Now you can see non-English news...

Corona: Great Britain has approved the first vaccine - and wants to get started immediately

2020-12-02T23:10:01.889Z


UK approved the Biontech / Pfizer vaccine. The corona vaccine of the Swedish-British group AstraZeneca is being checked again.


UK approved the Biontech / Pfizer vaccine.

The corona vaccine of the Swedish-British group AstraZeneca is being checked again.

  • The UK

    has approved the

    corona vaccine *

    from

    Biontech

    and

    Pfizer *

    .

  • US immunologist

    Anthony Fauci

    described the

    corona vaccines *

    as "cavalry" in the fight against the pandemic *.

  • Health Minister

    Jens Spahn

    and Vice Chancellor

    Olaf Scholz

    expect the first vaccinations in

    Germany

    as early as December.

  • This news ticker is updated regularly.

Update from December 2nd, 9:10 a.m .:

The time has come!

The corona vaccine from partners

Biontech

and

Pfizer

has been

approved

in the

UK

.

The UK government granted the emergency license application.

The Mainz company and its US partner are now allowed to offer their vaccine in the first country ever.

The vaccine is available for immediate delivery - Britain plans to start vaccinations as early as next week.

The procedure for

approval in the

EU

is still ongoing.

The European Medicines Agency

Ema

wants to

decide on a recommendation for approval for the European market

by

December 29th

at the latest

.

"As a company based in the heart of Europe, today's milestone is immensely important to us as we continue to strive to enable global distribution after the potential approval of BNT162b2," said Biontech boss

Ugur Sahin

*.

Approval is also imminent

in the

USA

.

The US government announced that approval could take place in the first two weeks of December.

Corona vaccine: Great Britain wants to approve first vaccine

Update from November 28, 7.11 p.m.:

Great Britain wants to

approve

the corona vaccine from Biontech and Pfizer as early as next week.

This would make the UK the first western country with a verified vaccine.

Once approved, the drug could be delivered and distributed within hours.

The

Financial Times

claims to have found out from government circles.

The first vaccinations should take place

on

December 7th

.

Great Britain is said to have ordered 40 million vaccine doses.

Biontech and Pfizer developed the vaccine BNT162b2.

It promises 95 percent effectiveness.

The German Biontech boss

Ugur Sahin

*

and his wife

Özlem Türeci

did research on vaccine development.

UK regulator set to approve Covid-19 vaccine next week https://t.co/p5rBdC6xIw

- Financial Times (@FT) November 28, 2020

Update from November 27, 4:50 p.m.:

On Friday,

Thailand

signed a contract with the British-Swedish pharmaceutical company

Astrazeneca

for the delivery of

26 million vaccine doses of

the

corona vaccine

AZD1222.

The vaccine should be available to the Southeast Asian country with its 69 million inhabitants in

mid-2021

, reported the

Bangkok Post

newspaper

.

A

research

fund

is also planned

so that the agent can also be produced in Thailand.

Prime Minister

Prayut Chan-o-cha

stressed on Thursday that he hoped

to be able to open up

the country to

mass tourism

again

.

"The more we push this schedule, the sooner we can open our doors to a large number of visitors and

start

rebuilding our economy

."

Corona: Doubts about study design and high effectiveness of the Astrazeneca vaccine

Update from November 27th, 3:10 p.m.:

The

British regulatory authority for drugs

is to

review

the

corona vaccine of

the pharmaceutical company

AstraZeneca

on behalf of the government

.

This is a "first, important step in the approval of the vaccine, if it meets the safety, effectiveness and quality standards," said the Ministry of Health in

London

on Friday

.

"We have formally asked regulators

to evaluate

the

vaccine

, understand the data and determine whether it

meets

strict safety standards

," said Health

Secretary

Matt Hancock

.

"We're working tirelessly to be in the best possible position to deliver a vaccine once it's approved by the independent MHRA regulatory agency."

We've formally asked the independent regulator @MHRAgovuk to assess the @ UniofOxford / @ AstraZeneca vaccine to determine if it meets rigorous safety standards.



We're working hard to be in the best possible position to deploy a #coronavirus vaccine as soon as one is approved.

- Matt Hancock (@MattHancock) November 27, 2020

Previously,

doubts had

arisen

about the study design

and the

high effectiveness of

the vaccine.

The Swedish-British group is therefore planning

additional investigations

.

A spokeswoman for

AstraZeneca

told

the

dpa

in London that

they should "supplement the data from existing studies"

without giving details.

According to

Pascal Soriot

, the head of the British-Swedish pharmaceutical company,

results of

90 percent effectiveness were obtained

in a group of

test

persons

.

The test subjects initially received

half a dose

and a month

later a full dose of

the vaccine.

A

second test group

had received the full active ingredient twice - but here the effectiveness was only

62 percent

.

The problem: in the group of

study participants

who were given a low dose,

nobody was over 55 years old

, reports

Bild

.

It

is therefore not known

whether the

vaccine will also be

as effective in high-

risk groups

.

Soriot

announced that the

new study would test

the effectiveness of the vaccine at the lower dose.

Corona vaccine: Moderna wants to start delivery in December

Update from November 26th, 11.49 a.m.:

The US manufacturer

Moderna

wants to start delivering its

corona vaccine

to the

European Union

as early as December - provided the agent receives approval.

The company announced this on Wednesday.

It confirmed the conclusion of a

framework agreement

with the EU Commission.

Accordingly,

80 million vaccine

doses are to be delivered

initially

, with the option of 80 million more units.

We just announced that the European Commission has approved an agreement to secure 80 million doses of mRNA-1273, with the option to increase their purchase to a total of up to 160 million doses.

Read more: https://t.co/G5wLVcGR51 #mRNA pic.twitter.com/lSTZQ5eMAt

- Moderna (@moderna_tx) November 25, 2020

"

Moderna

is assuming that it will start delivering mRNA-1273 to the European Union in December 2020", the company confirmed at the request of the

dpa

.

Strategic partners in Europe are

Lonza

in

Switzerland

and

Rovi

in

Spain

for the production and filling of the

vaccine

.

Corona vaccine: "Vaccine is not a magic potion" - Hofreiter calls for solidarity

The Bavarian Prime Minister

Markus Söder spoke

about the

Corona

vaccine

after the

Corona summit

on Wednesday

.

"The vaccine works, but it's not a magic potion and it doesn't just give you the caution and prudence we need," he said.

In

his speech in the

Bundestag

on Thursday,

Greens parliamentary group leader

Anton Hofreiter

called for

solidarity

with the global

distribution of corona vaccines

.

"The question will be whether the global right or wrong of the fittest applies, or whether we distribute the vaccines in solidarity," he said.

That will burn into billions of people and decisively

shape

the

international order

for the next few years, emphasized

Hofreiter

.

"We have a great

opportunity as rich countries, as the West, to ensure solidarity."


Corona vaccine: Chinese manufacturer applies for approval

Update from November 25, 1:25 p.m.:

According to a report by the Chinese news agency

Xinhua Finance

on Wednesday, the first manufacturer in

China has applied

for 

approval of a corona vaccine

for the general public.

The vaccine developer

China National Biotec Group (CNBG)

had submitted an application for approval of its preparation to the authorities


, it said.

The agency relies on a manager of the CNBG parent company

Sinopharm

.

It

is difficult to

compare the

corona vaccine

with that of the western manufacturers.

Neither

CNBG

nor

Sinopharm

have

made

any

more precise data on the effectiveness of their vaccine.

According to its own information from last week, Sinopharm has already

vaccinated

almost one million people

against the

coronavirus

using a so-called

emergency program

 with its

vaccine candidates

.

There have been no reports of serious side effects.

Only a few people would have developed mild symptoms. 

Chinese state media have been

reporting on

vaccinations for

certain population groups

for weeks

.

Military personnel and hospital staff, as well as diplomats and employees of state corporations are

vaccine candidates

administered the

test

in clinical trials

not completed

is.

Corona: Opel offers factory space for regional vaccination centers

Update from November 25, 8:34 a.m.:

The car manufacturer

Opel

has offered the states of

Hesse

,

Rhineland-Palatinate

and

Thuringia

to

set up

regional corona vaccination centers

in their plants

.

Areas and buildings are ready, said Opel boss

Michael Lohscheller

on Wednesday of the

dpa

.

"With large factory halls and parking areas as well as good connections to the local public transport network, our locations have excellent logistical prerequisites to specifically support and facilitate the

vaccination process

as soon as a

vaccine is

available", Lohscheller promoted his idea.

In addition to the headquarters in

Rüsselsheim

near Frankfurt, the car manufacturer also has plants in

Kaiserslautern

and

Eisenach

.

In Rüsselsheim the site is oversized, so parts have already been sold.

The

Opel boss

described the fight against the

Covid-19

disease

as a task for society as a whole, in which everyone had to help.

He said: “We want to do our part.

Because people's health has top priority. "

Corona: FDP parliamentary group leader Lindner demands "offensive for vaccination protection"

Update from November 24th, 5:50 pm:

With a view to the corona pandemic, FDP parliamentary group leader

Christian Lindner has

demanded

an

"offensive for vaccination protection"

from the federal government

.

"The willingness to be vaccinated is still too low measured by the degree of threat and the restriction of freedom," said Lindern on Tuesday in

Berlin

before a meeting of the FDP parliamentary group.

"It is the responsibility of the federal government to work now to ensure that people get vaccinated."

Initially, however, the deliberations of Chancellor Angela Merkel and the Prime Ministers of the federal states on Wednesday (November 25th) will be the focus.

The first details leaked out even before the Corona summit.

Corona vaccine: EU Commission signs framework agreement with Moderna

Update from November 24th, 1:45 p.m.:

The

EU Commission

has

negotiated

a framework agreement for

up to 160 million doses of

the

corona vaccine from

the US company

Moderna

.

The Commission chief

Ursula von der Leyen announced

on Tuesday.

The contract is to be formally sealed on Wednesday.

The

EU Commission

now has contracts with the manufacturers of all three

corona vaccines

, which are given the best chances for rapid approval in the coming weeks.

In addition to

Moderna

, these are

Biontech / Pfizer

and

Astrazeneca

.

All three had

announced

promising test data

in the past few days

.

Accordingly, all three vaccines are effective and well tolerated.

No one has

Corona vaccine

a

European approval

.

The

Federal Government and the EU Commission expect the

first

licenses to

be

issued

in

December

.

Before this, however, an examination by the European Medicines Agency (EMA) is necessary.

Tomorrow we will approve a 6th contract for up to 160 million doses of the @moderna_tx vaccine.



We're building one of the most comprehensive # COVID19 vaccine portfolios in the🌍Safe & effective vaccines can help us end the pandemic.

https://t.co/ymfqmMLWIJ

- Ursula von der Leyen (@vonderleyen) November 24, 2020

The

EU Commission

concludes

framework agreements

with manufacturers

on behalf of the 27 member states

.

On the one hand, these contracts contain advance payments so that the pharmaceutical companies can set up production quickly, and on the other hand, rights of first refusal for the EU countries.

Once a drug has been approved, all 27 states are to have

access to

it

at the same time

, although initially only in small quantities depending on production capacity.

They are distributed in the EU

according to the size of the population

.

Germany

has a share of

18.6 percent

.

In Germany, on the other hand,

risk groups

and

health workers

are

likely to be

vaccinated first.

It will be months before everyone gets the chance to get a vaccination.

Corona vaccine: According to the manufacturer, "Sputnik V" is 95 percent effective

Update from November 24th, 12:17 pm

: According to its manufacturer, the Russian corona vaccine "Sputnik V" is 95 percent effective.

This is the result of a second interim analysis of the data from clinical studies, announced the Russian Ministry of Health, the state research center Gamaleja and the Russian state fund RDIF in a joint statement on Tuesday.

Almost two weeks ago, Russia reported a 92 percent effectiveness of "Sputnik V".

The analysis is based on preliminary data from patients who had received the first dose of the vaccine 42 days earlier, the statement said.

However, it remained unclear how many test cases had been taken into account.

Russia had already approved "Sputnik V" in August without waiting for the final test phase with the tens of thousands of test subjects.

The second vaccine, "EpiVacCorona", was approved in mid-October.

Corona vaccine

effectiveness

storage

Vaccine type

Sputnik V (Russia)

95 percent effective

dry form of the vaccine can be stored at 2 to 8 degrees

Adenovirus-based vector virus vaccine

Pfizer Biontech vaccine (USA, Germany)

95 percent effective

Storage at minus 70 degrees

mRNA vaccine

Moderna (USA)

94.5 percent effective

Storage probably at minus 70 degrees

mRNA vaccine

AstraZeneca and Oxford University (Sweden, UK)

70 percent effective

Refrigerator temperature of two to eight degrees

Vector virus vaccine

+

"Sputnik V" - Russia reports 95 percent effectiveness of corona vaccine.

© Sputnik

Corona vaccine: First airline wants to introduce mandatory vaccination for passengers

Update from November 24th, 7:22 am:

"We will require international travelers to be vaccinated before we let them on board," said

Alan Joyce

, head of the Australian airline

Qantas

, in an interview with the broadcaster

Nine News

on Monday.

Concerned about the further spread of the

corona virus

, the company wants to

introduce

compulsory vaccination for passengers

on intercontinental connections.

A decision has not yet been made on how to proceed with domestic flights.

As soon as a

vaccine is

available, the

airline's

terms

and conditions will be adjusted accordingly,

Joyce

said

.

He assumes that his airline is not alone in this, but that

similar rules will be

introduced worldwide.

"I think this will be a normal thing, judging from conversations with my colleagues from other airlines."

#BREAKING: QANTAS CEO confirms that proof that you've been vaccinated for COVID-19 will be compulsory for international air travel onboard his aircraft.

# 9ACA pic.twitter.com/dhk3Hsnxn9

- A Current Affair (@ ACurrentAffair9) November 23, 2020

Corona vaccine: Health Minister Spahn visits IDT Biologika

Update from November 23, 9.42 a.m.:

Health Minister

Jens Spahn

and

Reiner Haseloff

, Prime Minister of Saxony-Anhalt, inform during their visit to the vaccine manufacturer

IDT Biologika

in Dessau-Roßlau in a press conference about the state of research.

The two politicians answer questions after a tour of the company.

Alongside

CureVac

and

BioNTech,

IDT

is

the third German company * that is

raising

hopes for successful coronavirus vaccines.

The federal government wants to secure at least five million vaccine doses from IDT, said Spahn.

130 million euros would be made available in research funds, an additional 30 million would be invested in the company in advance in order to secure production.

There is reason to hope that vaccinations against Sars-CoV-2 can be started at the beginning of next year, possibly even at the end of this year, the Minister of Health continued

(see also update 7.10 a.m.)

.

The vaccine from IDT will only be available later than the preparations from the other companies.

Corona vaccine: Next breakthrough company - 70 percent effectiveness

Update from November 23, 8:34 a.m.:

Next breakthrough in

vaccine research

in the fight against the novel

coronavirus Sars-CoV-2

: Another company, the British-Swedish pharmaceutical company

Astrazeneca has presented

positive data on a corona vaccine that is intended for Europe is relevant.

The vaccine avoids with around

70 percent probability

of contracting

Covid-19

, the company announced on Monday based on data from the important test phase III.

The effectiveness of the vaccine is, however, behind that of the preparations from Pfizer / Biontech and Moderna.

The vaccine was developed together with Oxford University.

Both single and double vaccination data were taken into account.

According to preliminary data, the effectiveness of the vaccines from Pfizer / Biontech and Moderna is around 95 percent for double vaccinations.

Advantage of the Astrazeneca vaccine

: According to the information, the preparation can be stored at refrigerator temperatures of two to eight degrees.

The

active ingredient AZD1222

is based on the weakened version of a

chimpanzee cold

virus

.

It contains genetic material from a surface protein with which the Sars-CoV-2 pathogen docks onto human cells.

The agent works in two ways: It is supposed to promote the formation of specific antibodies as well as T cells - both are important for the immune system.

Unlike the vaccines from the Mainz company Biontech and the pharmaceutical company Pfizer as well as the US company Moderna, the British-Swedish preparation does not belong to the mRNA vaccines.

Corona vaccinations earlier than expected?

"Reason for optimism": Spahn and Scholz name a possible time for corona vaccinations

Update from November 23, 7:10 am:

“There is reason to be optimistic that a vaccine will be approved in Europe this year.

And then we can start immediately with the vaccinations, ”said Federal Minister of Health

Jens Spahn to

the

editorial network Germany

.

He asked the federal states that the

vaccination centers

should be

ready for use in

mid-December

.

That seems to work.

Finance Minister

Olaf Scholz

also raised hopes for

corona vaccinations

this year.

"We have made the preparations so that it could start in December," said the Vice Chancellor on Sunday evening on

Bild live

.

He thinks that “the vaccination starts faster than we thought some time ago,” emphasized

Scholz

.

Spahn

was optimistic that it would

not take until the end of 2021

for

all population groups to be vaccinated

.

For example, many of the likely vaccines

do not require deep cooling

.

They could be given in normal

doctor's offices

.

"And then it goes quickly: Let's not forget that in a few weeks up to 20 million people are vaccinated against flu every year," said Spahn.

Corona vaccine: Spahn announces the establishment of an online platform

He also announced the

establishment of an online platform

on the

vaccination rates

achieved

, differentiated according to

age

and

region.

"Especially if we have achieved a high vaccination rate among the particularly vulnerable population groups, we will be able to gradually relax the restrictions."

According to

Spahn

,

Germany

has

now

secured

more than 300 million vaccine doses

for Germany

through the

EU Commission

or bilateral agreements and options

.

"Even with two doses per vaccination, we would have enough for our own population and could share it with other countries," said Spahn.

The Minister of Health announced that Germany will also

secure

vaccination doses from the Dessau vaccine manufacturer

IDT

.

He and Saxony-Anhalt's Prime Minister

Reiner Haseloff visited

the manufacturer on Monday.

Corona vaccine: Research Minister reaffirms security

Update from November 21, 9:05 a.m.:

Federal Research

Minister

Anja Karliczek

has

emphasized

the safety of the new potential

corona vaccines

.

"The vaccine will meet the same safety standards as all the others," Karliczek told the

Neue Osnabrücker Zeitung

.

"This also means that the authorities will continue to provide close support after approval and have an eye on the

safety

and

effectiveness of

the vaccine - exactly how it usually works." She added: "So nobody needs to worry." Karliczek emphasized: "The

vaccination remains absolutely voluntary

."

Corona vaccine: Biontech and Pfizer have applied for emergency approval

Update from November 20, 9:55 p.m.: Biontech

and

Pfizer

had already announced it, now the two companies have

actually applied for

emergency

approval

for their

corona vaccine

from the US FDA.

Pfizer confirmed this on Friday on Twitter.

If the active ingredient is approved, particularly vulnerable people in the

USA

could be

vaccinated as early as mid to late December.

"Applying for an emergency license in the US is a crucial step in making our vaccine candidates

available to

the

world's population

as quickly as possible

," said Biontech co-founder

Ugur Sahin

.

Pfizer boss

Albert Bourla

spoke in an Internet video of a "historic day for science and all of us".

We are submitting our first request for an #EUA in the US for vaccine candidate # BNT162b2 against # covid19.

We look forward to continuously providing data to various regulatory authorities as part of our rolling review process - including the @EMA_News.

https://t.co/Lk7MTlwE5R pic.twitter.com/OjZ2IxiU3a

- BioNTech SE (@BioNTech_Group) November 20, 2020

Corona vaccine: Olaf Scholz calls for global solidarity

Update from November 20, 4:50 p.m.:

Finance Minister

Olaf Scholz

has called on the leading

economic

nations

to participate

in the international

Covax corona vaccination initiative

.

"Germany and Europe have already pledged substantial financial

resources

here," said the Vice Chancellor after consultations with the

G20

finance ministers on Friday.

Germany

is the second largest donor.

But: "It is necessary that all G20 countries participate," explained

Scholz

.

According to the Ministry of Finance, a total of

around 4.3 billion euros has been made available

for the

development

and globally

fair distribution

of

corona vaccines

.

The latest news on this gave hope, said

Scholz

.

A

global

alliance is now

necessary to ensure fair and equitable access to vaccines.

Corona vaccine: USA plans delivery within 24 hours of approval

First report from November 20:

Munich / Washington - In the past few days, several companies have reported great successes in developing their

corona vaccine

.

Chancellor

Angela Merkel

spoke on Thursday evening that a vaccine could be approved in Europe in December or “very quickly after the turn of the year”.

The Mainz company

Biontech *

and its US partner

Pfizer

want to

apply for

state emergency approval

in the

US

for their

corona vaccine

on Friday

.

“We will be shipping millions of vaccine doses within 24 hours of FDA approval.

So my message is: Hope and help are on the way, "said US

Secretary of

Health

Alex Azar

at a briefing for the

coronavirus *

task force of

the White House on Thursday.

The government hopes that if the decision is positive,

millions of doses of the vaccine

could be available before the end of the year.

Azar also

reported that it is expected that the American vaccine developer

Moderna will

also soon ask for permission for its vaccine.

He praised the work of the scientists.

"In the past two weeks we have seen

unprecedented historical news

about vaccines," said the US Secretary of Health.

Most recently, there were

more than 2,200

corona deaths

in just one day

in the

United States

.

Corona vaccine: "Operation Warp Speed" is intended to ensure rapid distribution

“The goal is to make this vaccine as convenient for people to distribute as the flu vaccine,” said

Azar

.

A

comprehensive distribution plan

, based on a public-private partnership, is already in place.

Army General

Gustave Perna

, head of this so-called

"Operation Warp Speed"

, assured that there would be

no delivery bottlenecks

.

“We can ship the vaccine doses anywhere a US state wants to give them.

You can go to one central location or 10,000 different locations, ”he said.

Around 100 million vaccine containers are already ready.

Once Emergency Use Authorization comes, "24 hours later, vaccines will be distributed to the American people and be ready for administration."

pic.twitter.com/3m2gSSJduh

- The White House (@WhiteHouse) November 19, 2020

Coronavirus: US immunologist Fauci describes vaccine as "cavalry" in the fight against the pandemic

The renowned US immunologist

Anthony Fauci

also spoke about the

corona vaccines *

at the briefing

.

"The speed of the process has not compromised security in any way," he affirmed.

Fauci rejected concerns that the development of

corona vaccines

should have been accelerated at the expense of tolerability and effectiveness.

The data from the studies on the vaccines were

judged

by

independent experts

who owed no one, including the government.

Fauci

called on the American people to

continue to follow

the "simple" 

measures

to prevent

corona infections *

.

You should wear masks, keep your distance and avoid crowds.

He described the effective

corona vaccines *

as the "cavalry" in the fight to contain the

pandemic

.

“When you are fighting in a battle and the cavalry is on the way, you don't stop shooting.

You keep going until the cavalry is there - and then you might want to keep fighting, ”said Fauci.

(ph) * Merkur.de is part of the Ippen-Digital editorial network

List of rubric lists: © picture alliance / Marcus Brandt / dpa

Source: merkur

All news articles on 2020-12-02

You may like

News/Politics 2024-03-16T18:46:42.470Z
News/Politics 2024-03-18T14:18:09.201Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.